Results 11 to 20 of about 50,529 (255)

Paratesticular spindle cell rhabdomyosarcoma [PDF]

open access: yesRare Tumors, 2015
Spindle cell rhabdomyosarcoma is a rare variant of embryonal rhabdomyosarcoma that affects young males and most commonly involves the paratesticular region.
Biswajit Dey   +5 more
doaj   +2 more sources

Rhabdomyosarcoma of the kidney [PDF]

open access: yesJournal of Pediatric Surgery Case Reports, 2018
Rhabdomyosarcoma is considered the most common soft tissue sarcoma arising in patients younger than 15 years old, accounting for 5%–10% of childhood solid tumors. Sarcoma of the kidney represents 1% of all primary renal malignancies.
Alaa Samkari, Haneen Al-Maghrabi
doaj   +2 more sources

Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation [PDF]

open access: yesHaematologica, 2010
Background Rhabdomyosarcoma is the most common soft tissue sarcoma in childhood and has a poor prognosis. Here we assessed the capability of ex vivo expanded cytokine-induced killer cells to lyse both alveolar and embryonic rhabdomyosarcoma cell lines ...
Selim Kuçi   +12 more
doaj   +2 more sources

Rhabdomyosarcoma-Induced Uterine Inversion [PDF]

open access: yesCase Reports in Obstetrics and Gynecology, 2022
Nonpuerperal uterine inversion is a rare clinical condition that involves prolapse of the uterine fundus into the uterine cavity and vaginal vault and possibly passed the introitus.
Kin Li   +3 more
doaj   +2 more sources

Pleomorphic rhabdomyosarcoma in adults: a case report [PDF]

open access: yesJournal of Medical Case Reports
Background Rhabdomyosarcoma is a rare type of soft-tissue sarcoma that is more frequently observed in children and is less common in adults. Rhabdomyosarcoma can occur in any part of the body, including tissues without skeletal muscles. The main subtypes
Zahra Aminparast   +2 more
doaj   +2 more sources

The Case for Primary Salivary Rhabdomyosarcoma [PDF]

open access: yesFrontiers in Oncology, 2015
Rhabdomyosarcomas of the parotid and submandibular glands have the histological appearance of a skeletal muscle tumor yet can be found in tissue with no striated muscular elements. We examine the potential cell-of-origin for rhabdomyosarcoma and whether
Mathew eGeltzeiler   +4 more
doaj   +2 more sources

Integrative Bayesian Analysis Identifies Rhabdomyosarcoma Disease Genes [PDF]

open access: yesCell Reports, 2018
Summary: Identifying oncogenic drivers and tumor suppressors remains a challenge in many forms of cancer, including rhabdomyosarcoma. Anticipating gene expression alterations resulting from DNA copy-number variants to be particularly important, we ...
Lin Xu   +11 more
doaj   +2 more sources

Can Response Outcomes Predict Survival in Paediatric Patients Receiving Treatment for Relapsed and Refractory Rhabdomyosarcoma? Results From the Living-REFoRMS Systematic Review. [PDF]

open access: yesInt J Cancer
Although existing research suggests a limited relationship between survival outcomes and radiological response rates in children with newly diagnosed rhabdomyosarcoma, there is little evidence in the relapsed/refractory setting. Using aggregate data collected from the Living‐REFoRMS dataset of early‐phase trials, the authors established that ...
Muthukumar P   +4 more
europepmc   +2 more sources

Proton beam therapy in paediatric cancer: Anticipating the opening of the Australian Bragg Centre for Proton Therapy and Research

open access: yesJournal of Medical Imaging and Radiation Oncology, EarlyView., 2023
Summary Proton Beam Therapy (PBT) has the potential to improve paediatric cancer care by reducing radiation exposure and thus long‐term toxicities. Ethical concerns and debates surrounding the treatment, such as eligibility and accessibility, are ongoing in Australia. The Australian Bragg Centre for Proton Therapy and Research (ABCPTR) (named after Sir
Jeremy Khong   +10 more
wiley   +1 more source

Cell death pathways as therapeutic targets in rhabdomyosarcoma [PDF]

open access: yes, 2012
Resistance of rhabdomyosarcoma to current therapies remains one of the key issues in pediatric oncology. Since the success of most cytotoxic therapies in the treatment of cancer, for example, chemotherapy, depends on intact signaling pathways that ...
Fulda, Simone
core   +1 more source

Home - About - Disclaimer - Privacy